Skip to main content
. 2017 Dec 20;22(3):1614–1626. doi: 10.1111/jcmm.13436

Figure 2.

Figure 2

ATO combined with Dasatinib induces apoptosis. (A) SUP‐B15 and TOM‐1 cells were treated with the indicated concentrations of ATO and/or Dasatinib for the indicated time courses. Apoptosis was measured by flow cytometry with FITC‐Annexin‐V/PI staining. (B) Western blot detecting caspase‐9,3 and PARP in SUP‐B15 and TOM‐1 cells treated with ATO and/or Dasatinib at the indicated concentrations for 24 hrs. Each bar represents the mean ± S.E.M, n = 3. **P < 0.01; ***P < 0.001 versus ATO, Dasatinib and control group.